Nov 22,2022

Dexcom Announces Upcoming Conference Presentation

DexCom today announced that Matt Dolan, Executive Vice President, Strategy, Corporate Development and Dexcom Labs, will present an update on the company at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at 8:30am (EST).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 22,2022

Insulet to Present at Upcoming Investor Conferences

Insulet Corporation today announced that management will present at two upcoming investor conferences: The Nasdaq 47th Investor Conference in London on Tuesday, December 6, 2022 at 6:30 a.m. (Eastern Time). The J.P. Morgan 41st Annual Healthcare Conference in San Francisco on Tuesday, January 10, 2023 at 1:30 p.m. (Eastern Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 23,2022

Insulin Pump Market is Projected to Reach US$ 9.7 Bn at a CAGR of 10.3% by year 2032-end, Amid Steady Increase in Diabetes Incidence, and a Surge in Prevalence of Obesity | Future Market Insights, Inc.

The Insulin Pumps Market revenues were estimated at US$ 5.5 Bn in 2022 and is anticipated to grow at a CAGR of 10.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 14.8 Mn. The demand for tethered pumps is projected to garner an absolute dollar opportunity of US$ 6.7 Bn during 2022 – 2032.

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Nov 23,2022

Medtronic reports 3% decline in Q2 2023 global revenue

Medtronic has reported $7.585bn global revenue for the second quarter (Q2) of the fiscal year 2023 (FY23), representing a 3% decline as reported and 2% increase on an organic basis. This organic comparison excludes $25m from the Intersect ENT acquisition as well as a $457m negative impact from foreign currency translation. For the quarter, which ended on 28 October, the company’s GAAP net income was $427m and diluted earnings per share (EPS) stood at $0.32, both represented a 67% decline compared to the same quarter of the previous year.

View Analyst & Ambassador Comments
Go to original news
Nov 23,2022

Brighter files for bankruptcy

In light of the district court's decision on November 21, 2022 that the corporate restructuring must cease, the board of Brighter AB has decided that the company will file for bankruptcy. The application has been sent to Solna District Court.

View Analyst & Ambassador Comments
Go to original news
Nov 26,2022

Leading medical companies in the remote patient monitoring theme

Remote patient monitoring (RPM) is the use of digital technologies and services to monitor, analyse, and capture the health data of patients and send this information to healthcare professionals for further evaluation. RPM devices can greatly improve the management of various chronic conditions. The primary goal of RPM devices is to accurately collect a wide range of health data for a patient, such as blood pressure, heart rate, vital signs, weight, and blood sugar levels. The patient’s health information is then transmitted to healthcare specialists for monitoring and evaluation, with patients staying at home rather than visiting healthcare facilities.

View Analyst & Ambassador Comments
Go to original news
Nov 28,2022

Ypsomed, CamDiab launch first automated insulin dosing system with Abbott FreeStyle Libre 3

The Ypsomed mylife YpsoPump combines with the CamDiab mylife CamAPS FX algorithm and FreeStyle Libre 3. Together, they form an intelligent and automated insulin delivery (AID) system for people with type 1 diabetes. Users can better control glucose levels and alleviate the burden of daily diabetes management.

PRODUCT

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Nov 30,2022

Q&A: How Carbon Health plans to modernize 'disconnected' chronic care

In 2021, omnichannel healthcare provider Carbon Health acquired Steady Health, an integrated diabetes care platform, and earlier this year launched its own management program. Myoung Cha, chief strategy officer at Carbon Health, spoke with MobiHealthNews via email to discuss the program's results, how his previous experience at Apple influences his decisions, and how combining in-person care and technology will drive Carbon Health's platform in the future.

#virtual care

#mobile app

#cgm

View Analyst & Ambassador Comments
Go to original news
Nov 30,2022

Carbon Health Announces Best-in-Class Patient Outcomes from Diabetes Program

In honor of National Diabetes Awareness Month in November, Carbon Health, a hybrid healthcare company that combines expert care with proprietary technology for easy everyday health, announces compelling new patient outcomes from its innovative diabetes program. To date, Carbon Health's diabetes program has helped two-thirds of its patients with uncontrolled diabetes (A1c ≥7.0%) achieve and maintain recommended glycemic targets, while patients with baseline A1c >9.0% in particular saw an impressive average A1c reduction of 4.2%.

PRODUCT

#mobile app

#virtual care

View Analyst & Ambassador Comments
Go to original news
Oct 13,2022

CCS Announces Innovative Partnership with Welldoc and ZeOmega

CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — has announced a partnership with Welldoc and ZeOmega to expand its established LivingConnected solution. The Welldoc digital health tool allows individuals to track device readings and access coaching, and the ZeOmega platform captures utilization patterns and claims data. With the combination of these digital health products powering the LivingConnected® program, certified CCS clinicians will now have real-time visibility into glycemic control to customize member engagement and guide necessary clinical interventions.

COLLABORATION PARTNERSHIP

#connected device

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES